Active	Status	Sponsor type	Region	Phase	Filter
3 Active 3 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Picardi, Marco
RAFTING, NCT04866654 / 2020-002382-33: Radiation Free Chemotherapy for Early Hodgkin Lymphoma	Recruiting	2	160	Europe	Nivolumab 10 MG/ML	Medical University of Gdansk, Medical Research Agency	Hodgkin Lymphoma	09/22	07/26
EPICOVIDEHA, NCT04733729: Covid-19 in Hematological Malignancies	Recruiting	N/A	3000	Europe		Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne, European Hematology Association	COVID-19 Infection in Hematological Malignancies Patients	09/22	03/24
PIMENTO, NCT04333524: FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role	Recruiting	N/A	350	Europe		International Extranodal Lymphoma Study Group (IELSG)	Marginal Zone Lymphoma	12/25	12/25